Life Sciences Industry Says FDA Needs Reform

Law360, New York (May 23, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration suffers from staffing shortages, drawn out reviews, backlogs of applications and a lack of resources, according to a survey of the top pharmaceutical, biotechnology and life sciences companies.

The industry’s views of the FDA’s drug and medical device approval process emerged in a survey released on Wednesday by PricewaterhouseCoopers LLP and BIOCOM, a life sciences industry association that represents 550 companies in southern California.

“This study is intended to be a working document between the industry and the FDA to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.